INS and early-onset autosomal dominant Alzheimer disease: In recent years, the administration of intranasal insulin and of drugs which enhance cell sensitivity to this hormone was shown to improve cognitive function in patients with Alzheimer’s disease, mild cognitive impairments, or diabetes mellitus, as well as in animal models of these diseases [4,5,6,27,28,30,68].